Post-COVID-19 Lung Transplantation Italian Pivotal Protocol: Some Ethical Considerations

Area of Science:

• Pulmonology
• Transplant Surgery
• Infectious Diseases

Background:

• SARS-CoV-2 primarily impacts the respiratory system, leading to conditions from common colds to fatal pneumonia.
• A subset of patients experiencing terminal respiratory failure post-COVID-19 may require lung transplantation for survival.
• Successful lung transplants in post-COVID-19 patients are increasingly reported globally.

Purpose of the Study:

• To establish a protocol for lung transplantation in patients with SARS-CoV-2-related lung damage.
• To evaluate the safety and efficacy of lung transplantation for post-COVID-19 patients.
• To inform ethical organ allocation criteria for lung transplants, considering post-COVID-19 cases.

Main Methods:

• Development of a pivotal observational protocol by Milan's Policlinic Lung Transplant Surgery Unit.
• Revision of the protocol with the National Second Opinion for Infectious Diseases and Italian transplant centers.
• Approval of the protocol by the Italian National Institute of Health Ethics Committee.

Main Results:

• The protocol focuses on patients who were infected with SARS-CoV-2 and subsequently tested negative, but developed lung sequelae.
• Sequelae include acute respiratory distress syndrome (ARDS) and chronic interstitial lung disease.
• The protocol aims to ensure sound ethical criteria for organ allocation in lung transplantation.

Conclusions:

• Lung transplantation is a critical intervention for select patients with severe post-COVID-19 respiratory failure.
• A structured protocol is essential for managing these complex cases and ensuring equitable organ distribution.
• Ethical considerations are paramount in organ allocation for lung transplants, especially with the growing number of post-COVID-19 candidates.